After establishing presence in Hyderabad, this launch expands footprint in South India
Bengaluru, India, April 12, 2023: Global pharma major Lupin Limited (Lupin) announced today the launch of its new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of the expansion of its diagnostics network. The new laboratory marks a significant step forward in Lupin Diagnostics’ mission to provide accessible and affordable diagnostics and preventive healthcare services across India. The Regional Reference Laboratory complements the company’s existing network of 25 laboratories and 410+ collection centers across India.
The new laboratory in Bengaluru is equipped with cutting-edge technologies and staffed by highly qualified clinical experts, enabling Lupin Diagnostics to deliver high-quality and reliable diagnostic services to patients and consumers across Bengaluru and neighboring cities.
In addition to routine and specialized tests, the laboratory offers a comprehensive range of diagnostics services, including molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, histopathology, immunology, routine biochemistry, among others. Lupin Diagnostics leverages state-of-the-art automation and streamlined processes to deliver highly accurate test results, empowering patients to make informed decisions about their health. 
“Ensuring that quality diagnostics are accessible and affordable for everyone in India is at the core of our mission,” says Ravindra Kumar, CEO of Lupin Diagnostics. “Accurate diagnosis is crucial for effective disease management, and we are committed to providing our patients with reliable, high-quality diagnostic services. With our cutting-edge technology and personalized smart reports, patients and doctors can gain valuable insights into health trends and make informed decisions about treatment options,” he added.
